NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/15/2024
Back to search
Official data from USPTO
NMS GROUP ONCOLOGY FORWARD
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
11/15/2024
Trademark type
Combined
Nice classes
42
Filing date
07/09/2021
Registration date
01/31/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/31/2023
Last transaction
01/31/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
09
Owner location
IT
Examiner
RENNEKER, CHRISTOPHER
Law office
N30
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stacked stylized wording "NMS GROUP," in block letters, and "ONCOLOGY FORWARD".
Holders and representatives
Holders
NMS GROUP S.P.A.
Representatives
Jeffrey B. Sladkus, Esq. The Sladkus Law Group
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Scientifictechnologicalanalysis and research servicesresearch and development in the field of medicinetesting in the field of pharmaceuticals and gene-based drugs and therapies; biological research in the field of medicinetesting in the field of pharmaceuticals and gene-based drugs and therapies; chemical research in the field of medicinetesting in the field of pharmaceuticals and gene-based drugs and therapies; clinical trials in the field of medicinetesting in the field of pharmaceuticals and gene-based drugs and therapies; quality control in the field of medicinetesting in the field of pharmaceuticals and gene-based drugs and therapies; scientific laboratory services
Publications
History of USPTO decisions and trademark events.
33 publications found
FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
05/23/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/04/2023
FIMP
FINAL DISPOSITION PROCESSED
05/04/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/30/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/31/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
01/31/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/15/2022
PUBO
PUBLISHED FOR OPPOSITION
11/15/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/26/2022
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
10/04/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/20/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/17/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/16/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/16/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/12/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/12/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
09/12/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/12/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/12/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/12/2022
RFNT
REFUSAL PROCESSED BY IB
06/06/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/18/2022
RFRR
REFUSAL PROCESSED BY MPU
05/18/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/06/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/06/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/06/2022
ALIE
ASSIGNED TO LIE
04/05/2022
CNRT
NON-FINAL ACTION WRITTEN
04/05/2022
DOCK
ASSIGNED TO EXAMINER
03/29/2022
MAFR
APPLICATION FILING RECEIPT MAILED
10/30/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/26/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/22/2021
Continuous trademark protection
Get notified about every new filing that threatens NMS GROUP ONCOLOGY FORWARD or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.